Share Price and Basic Stock Data
Last Updated: November 4, 2025, 7:20 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Elango Industries Ltd operates within the steel alloys and special steel sector, addressing niche demands in this industrial landscape. The company reported a market capitalization of ₹4.54 Cr and a share price of ₹11.9. Revenue trends indicate a fluctuating performance; after several quarters of zero sales from June 2022 to March 2023, the company recorded sales of ₹1.93 lakh in June 2023. This was followed by a modest decline to ₹0.65 lakh in December 2023 and projections of further minor sales in subsequent quarters, highlighting a volatile revenue stream. For the fiscal year ending March 2024, total sales stood at ₹2.58 Cr, a significant increase from ₹0.00 Cr in the previous year, while the trailing twelve months (TTM) revenue was ₹1.12 Cr. This inconsistent revenue pattern raises questions about the company’s operational stability and market demand. It is crucial to monitor future sales performance closely to assess the sustainability of this upward trend.
Profitability and Efficiency Metrics
The profitability metrics of Elango Industries Ltd reveal a challenging landscape. The operating profit margin (OPM) was reported at -23.81%, reflecting significant operational inefficiencies. The company has consistently recorded negative operating profits over several quarters, with an operating profit of ₹0.00 in June 2023 and losses of ₹0.04 lakh in March 2023. Additionally, net profit stood at -₹0.17 Cr, emphasizing ongoing financial struggles. The return on equity (ROE) and return on capital employed (ROCE) both reported at 5.67%, which is low compared to sector averages, indicating that the company is not effectively utilizing its equity and capital to generate profits. The cash conversion cycle of 3.80 days suggests some efficiency in managing receivables and payables, yet the overall profitability remains hindered by the negative margins, showcasing a need for operational improvements and strategic adjustments.
Balance Sheet Strength and Financial Ratios
Elango Industries Ltd’s balance sheet reflects a relatively stable structure, with total borrowings reported at ₹0.00 Cr, indicating no reliance on debt financing. However, reserves have declined to -₹0.05 Cr as of March 2025, which raises concerns about the company’s retained earnings and overall financial health. The current ratio, standing at 3.69, suggests a strong liquidity position, allowing the company to meet its short-term obligations comfortably. The price-to-book value (P/BV) ratio is recorded at 0.98x, indicating that the stock is trading at nearly its book value, which may attract value investors. However, the negative earnings per share (EPS) of -₹0.57 for March 2025 signals ongoing financial distress. The enterprise value (EV) of ₹3.73 Cr, along with a negative EV/EBITDA ratio, emphasizes the market’s skepticism about the company’s future cash flow generation capability. These financial ratios highlight both strengths in liquidity and weaknesses in profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Elango Industries Ltd indicates a significant public stake of 64.79%, while promoters hold 35.20%. The consistency in promoter shareholding over the past quarters suggests a stable governance structure and commitment to the company’s future. The total number of shareholders has shown slight fluctuations, recorded at 8,648 as of June 2025, which reflects a steady interest from the investing public despite the company’s financial challenges. The absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may be indicative of a lack of confidence in the company’s performance prospects. This could pose a risk as institutional investors typically provide stability and credibility to a stock’s valuation. The high public stake could also lead to volatility in the stock price, depending on market sentiment and operational performance.
Outlook, Risks, and Final Insight
The outlook for Elango Industries Ltd remains uncertain, with both potential strengths and risks ahead. On one hand, the company’s complete lack of debt positions it favorably against financial distress, allowing room for operational restructuring. However, persistent negative profitability and declining reserves pose significant risks that could hinder recovery efforts. If Elango Industries successfully executes a turnaround strategy, focusing on improving operational efficiency and sales growth, it may regain market confidence and improve its financial standing. Conversely, failure to address ongoing losses and maintain liquidity could lead to further declines in market perception and shareholder value. Investors should monitor the company’s quarterly performance closely, as the ability to convert recent sales into sustained profitability will be critical for future growth and stability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Elango Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Elango Industries Ltd | 4.82 Cr. | 12.6 | 16.1/8.45 | 9.88 | 0.00 % | 5.67 % | 5.67 % | 10.0 | |
| Ashnisha Industries Ltd | 87.2 Cr. | 3.29 | 4.79/2.57 | 363 | 2.29 | 0.00 % | 1.23 % | 0.28 % | 1.00 |
| Usha Martin Ltd | 14,451 Cr. | 474 | 488/279 | 35.8 | 90.3 | 0.63 % | 18.8 % | 15.8 % | 1.00 |
| Shah Alloys Ltd | 158 Cr. | 79.9 | 83.5/43.3 | 3.88 | 0.00 % | 25.8 % | 1,108 % | 10.0 | |
| Mukand Ltd | 1,973 Cr. | 137 | 162/84.4 | 24.5 | 65.7 | 1.47 % | 9.91 % | 7.84 % | 10.0 |
| Industry Average | 19,364.25 Cr | 240.80 | 111.73 | 62.51 | 0.42% | 13.27% | 192.30% | 5.67 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 1.93 | 0.00 | 0.65 | 0.00 | 0.04 | 0.00 | 0.90 | 0.01 | 0.21 |
| Expenses | 0.07 | 0.03 | 0.04 | 0.04 | 1.93 | 0.04 | 0.67 | 0.08 | 0.13 | 0.03 | 0.93 | 0.06 | 0.26 |
| Operating Profit | -0.07 | -0.03 | -0.04 | -0.04 | 0.00 | -0.04 | -0.02 | -0.08 | -0.09 | -0.03 | -0.03 | -0.05 | -0.05 |
| OPM % | 0.00% | -3.08% | -225.00% | -3.33% | -500.00% | -23.81% | |||||||
| Other Income | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.05 | -0.03 | -0.04 | -0.02 | 0.00 | -0.04 | -0.03 | -0.09 | -0.09 | -0.03 | -0.03 | -0.05 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.05 | -0.03 | -0.04 | -0.03 | 0.00 | -0.04 | -0.02 | -0.08 | -0.10 | -0.03 | -0.03 | -0.06 | -0.05 |
| EPS in Rs | -0.13 | -0.08 | -0.10 | -0.08 | 0.00 | -0.10 | -0.05 | -0.21 | -0.26 | -0.08 | -0.08 | -0.16 | -0.13 |
Last Updated: August 19, 2025, 7:30 pm
Below is a detailed analysis of the quarterly data for Elango Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2025) to 0.21 Cr., marking an increase of 0.20 Cr..
- For Expenses, as of Jun 2025, the value is 0.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Mar 2025) to 0.26 Cr., marking an increase of 0.20 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded -0.05 Cr..
- For OPM %, as of Jun 2025, the value is -23.81%. The value appears strong and on an upward trend. It has increased from -500.00% (Mar 2025) to -23.81%, marking an increase of 476.19%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded -0.05 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -0.06 Cr. (Mar 2025) to -0.05 Cr., marking an increase of 0.01 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.13. The value appears strong and on an upward trend. It has increased from -0.16 (Mar 2025) to -0.13, marking an increase of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:26 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.29 | 0.48 | 0.51 | 0.20 | 0.15 | 0.25 | 0.55 | 0.00 | 2.58 | 0.96 | 1.12 |
| Expenses | 0.24 | 0.75 | 0.30 | 0.27 | 0.59 | 0.43 | 0.11 | 0.31 | 1.08 | 0.17 | 2.71 | 1.16 | 1.28 |
| Operating Profit | -0.24 | -0.75 | -0.01 | 0.21 | -0.08 | -0.23 | 0.04 | -0.06 | -0.53 | -0.17 | -0.13 | -0.20 | -0.16 |
| OPM % | -3.45% | 43.75% | -15.69% | -115.00% | 26.67% | -24.00% | -96.36% | -5.04% | -20.83% | -14.29% | |||
| Other Income | 0.15 | 0.00 | 0.61 | 0.01 | 0.01 | 0.00 | 0.00 | 0.11 | 0.11 | 0.05 | 0.01 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 |
| Profit before tax | -0.11 | -0.75 | 0.60 | 0.22 | -0.07 | -0.23 | 0.04 | 0.05 | -0.45 | -0.14 | -0.14 | -0.22 | -0.16 |
| Tax % | 0.00% | 0.00% | 0.00% | 18.18% | 0.00% | 0.00% | 0.00% | 20.00% | 0.00% | 0.00% | 7.14% | 0.00% | |
| Net Profit | -0.10 | -0.75 | 0.60 | 0.18 | -0.07 | -0.23 | 0.04 | 0.04 | -0.45 | -0.15 | -0.14 | -0.22 | -0.17 |
| EPS in Rs | -0.26 | -1.97 | 1.57 | 0.47 | -0.18 | -0.60 | 0.10 | 0.10 | -1.18 | -0.39 | -0.37 | -0.58 | -0.45 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -650.00% | 180.00% | -70.00% | -138.89% | -228.57% | 117.39% | 0.00% | -1225.00% | 66.67% | 6.67% | -57.14% |
| Change in YoY Net Profit Growth (%) | 0.00% | 830.00% | -250.00% | -68.89% | -89.68% | 345.96% | -117.39% | -1225.00% | 1291.67% | -60.00% | -63.81% |
Elango Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 20% |
| TTM: | 62% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | % |
| 3 Years: | 15% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 33% |
| 3 Years: | 13% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -4% |
| 3 Years: | -4% |
| Last Year: | -6% |
Last Updated: September 5, 2025, 3:21 pm
Balance Sheet
Last Updated: July 25, 2025, 1:22 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 |
| Reserves | 1.15 | 0.31 | 0.91 | 1.09 | 1.02 | 0.79 | 0.83 | 0.91 | 0.46 | 0.31 | 0.17 | -0.05 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.06 | 0.06 | 0.07 | 0.07 | 0.13 | 0.04 | 0.04 | 0.10 | 0.07 | 2.40 | 0.74 | 0.94 |
| Total Liabilities | 5.03 | 4.19 | 4.80 | 4.98 | 4.97 | 4.65 | 4.69 | 4.83 | 4.35 | 6.53 | 4.73 | 4.71 |
| Fixed Assets | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.03 | 0.14 | 0.12 | 0.11 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 3.06 | 3.06 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 1.88 | 1.13 | 4.77 | 4.95 | 4.94 | 4.62 | 4.66 | 4.74 | 4.32 | 6.39 | 4.61 | 4.60 |
| Total Assets | 5.03 | 4.19 | 4.80 | 4.98 | 4.97 | 4.65 | 4.69 | 4.83 | 4.35 | 6.53 | 4.73 | 4.71 |
Below is a detailed analysis of the balance sheet data for Elango Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 3.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.82 Cr..
- For Reserves, as of Mar 2025, the value is -0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.17 Cr. (Mar 2024) to -0.05 Cr., marking a decrease of 0.22 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. However, Reserves are negative, which is a major warning sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.94 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.74 Cr. (Mar 2024) to 0.94 Cr., marking an increase of 0.20 Cr..
- For Total Liabilities, as of Mar 2025, the value is 4.71 Cr.. The value appears to be improving (decreasing). It has decreased from 4.73 Cr. (Mar 2024) to 4.71 Cr., marking a decrease of 0.02 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.11 Cr.. The value appears to be declining and may need further review. It has decreased from 0.12 Cr. (Mar 2024) to 0.11 Cr., marking a decrease of 0.01 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 4.60 Cr.. The value appears to be declining and may need further review. It has decreased from 4.61 Cr. (Mar 2024) to 4.60 Cr., marking a decrease of 0.01 Cr..
- For Total Assets, as of Mar 2025, the value is 4.71 Cr.. The value appears to be declining and may need further review. It has decreased from 4.73 Cr. (Mar 2024) to 4.71 Cr., marking a decrease of 0.02 Cr..
However, the Borrowings (0.00 Cr.) are higher than the Reserves (-0.05 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.24 | -0.75 | -0.01 | 0.21 | -0.08 | -0.23 | 0.04 | -0.06 | -0.53 | -0.17 | -0.13 | -0.20 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37.76 | 0.00 | 393.63 | 1,387.00 | 1,849.33 | 116.80 | 0.00 | 0.00 | 3.80 | |||
| Inventory Days | 0.00 | 0.00 | ||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 37.76 | 0.00 | 393.63 | 1,387.00 | 1,849.33 | 116.80 | 0.00 | 0.00 | 3.80 | |||
| Working Capital Days | 4,505.86 | -53.23 | 307.75 | 6,205.00 | 3,260.67 | 1,854.20 | 132.73 | 367.83 | 908.70 | |||
| ROCE % | -2.19% | -16.48% | 13.54% | 4.56% | -1.44% | -4.87% | 0.86% | 1.07% | -9.99% | -3.33% | -3.45% | -5.67% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.57 | -0.38 | -0.40 | -1.18 | 0.11 |
| Diluted EPS (Rs.) | -0.57 | -0.38 | -0.40 | -1.18 | 0.11 |
| Cash EPS (Rs.) | -0.52 | -0.32 | -0.33 | -1.09 | 0.11 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.87 | 10.44 | 10.82 | 11.21 | 12.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.87 | 10.44 | 10.82 | 11.21 | 12.39 |
| Revenue From Operations / Share (Rs.) | 2.51 | 6.75 | 0.00 | 1.44 | 0.65 |
| PBDIT / Share (Rs.) | -0.51 | -0.30 | -0.32 | -1.10 | 0.14 |
| PBIT / Share (Rs.) | -0.55 | -0.36 | -0.38 | -1.19 | 0.14 |
| PBT / Share (Rs.) | -0.55 | -0.36 | -0.38 | -1.19 | 0.14 |
| Net Profit / Share (Rs.) | -0.56 | -0.37 | -0.39 | -1.18 | 0.11 |
| PBDIT Margin (%) | -20.58 | -4.52 | -6510.52 | -76.52 | 21.96 |
| PBIT Margin (%) | -22.25 | -5.33 | -7705.26 | -82.68 | 21.88 |
| PBT Margin (%) | -22.25 | -5.33 | -7705.26 | -82.68 | 21.88 |
| Net Profit Margin (%) | -22.61 | -5.61 | -7931.57 | -81.87 | 17.05 |
| Return on Networth / Equity (%) | -5.74 | -3.62 | -3.64 | -10.49 | 0.90 |
| Return on Capital Employeed (%) | -5.58 | -3.40 | -3.53 | -10.59 | 1.15 |
| Return On Assets (%) | -4.60 | -3.05 | -2.30 | -10.32 | 0.88 |
| Asset Turnover Ratio (%) | 0.20 | 0.45 | 0.00 | 0.11 | 0.05 |
| Current Ratio (X) | 3.69 | 4.73 | 2.09 | 44.05 | 15.06 |
| Quick Ratio (X) | 3.69 | 4.73 | 2.09 | 44.05 | 15.06 |
| Enterprise Value (Cr.) | 3.73 | 4.06 | 1.53 | 1.85 | 0.81 |
| EV / Net Operating Revenue (X) | 3.89 | 1.57 | 804.07 | 3.37 | 3.23 |
| EV / EBITDA (X) | -18.89 | -34.74 | -12.35 | -4.41 | 14.72 |
| MarketCap / Net Operating Revenue (X) | 3.89 | 1.57 | 1661.39 | 8.50 | 3.44 |
| Price / BV (X) | 0.98 | 1.02 | 0.76 | 1.09 | 0.18 |
| Price / Net Operating Revenue (X) | 3.89 | 1.57 | 2065.00 | 8.50 | 3.44 |
| EarningsYield | -0.05 | -0.03 | -0.04 | -0.09 | 0.04 |
After reviewing the key financial ratios for Elango Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from -0.38 (Mar 24) to -0.57, marking a decrease of 0.19.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from -0.38 (Mar 24) to -0.57, marking a decrease of 0.19.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 3. It has decreased from -0.32 (Mar 24) to -0.52, marking a decrease of 0.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.87. It has decreased from 10.44 (Mar 24) to 9.87, marking a decrease of 0.57.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.87. It has decreased from 10.44 (Mar 24) to 9.87, marking a decrease of 0.57.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.51. It has decreased from 6.75 (Mar 24) to 2.51, marking a decrease of 4.24.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.51. This value is below the healthy minimum of 2. It has decreased from -0.30 (Mar 24) to -0.51, marking a decrease of 0.21.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 0. It has decreased from -0.36 (Mar 24) to -0.55, marking a decrease of 0.19.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 0. It has decreased from -0.36 (Mar 24) to -0.55, marking a decrease of 0.19.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 2. It has decreased from -0.37 (Mar 24) to -0.56, marking a decrease of 0.19.
- For PBDIT Margin (%), as of Mar 25, the value is -20.58. This value is below the healthy minimum of 10. It has decreased from -4.52 (Mar 24) to -20.58, marking a decrease of 16.06.
- For PBIT Margin (%), as of Mar 25, the value is -22.25. This value is below the healthy minimum of 10. It has decreased from -5.33 (Mar 24) to -22.25, marking a decrease of 16.92.
- For PBT Margin (%), as of Mar 25, the value is -22.25. This value is below the healthy minimum of 10. It has decreased from -5.33 (Mar 24) to -22.25, marking a decrease of 16.92.
- For Net Profit Margin (%), as of Mar 25, the value is -22.61. This value is below the healthy minimum of 5. It has decreased from -5.61 (Mar 24) to -22.61, marking a decrease of 17.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is -5.74. This value is below the healthy minimum of 15. It has decreased from -3.62 (Mar 24) to -5.74, marking a decrease of 2.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.58. This value is below the healthy minimum of 10. It has decreased from -3.40 (Mar 24) to -5.58, marking a decrease of 2.18.
- For Return On Assets (%), as of Mar 25, the value is -4.60. This value is below the healthy minimum of 5. It has decreased from -3.05 (Mar 24) to -4.60, marking a decrease of 1.55.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.20. It has decreased from 0.45 (Mar 24) to 0.20, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 3.69. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 3.69, marking a decrease of 1.04.
- For Quick Ratio (X), as of Mar 25, the value is 3.69. This value exceeds the healthy maximum of 2. It has decreased from 4.73 (Mar 24) to 3.69, marking a decrease of 1.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3.73. It has decreased from 4.06 (Mar 24) to 3.73, marking a decrease of 0.33.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For EV / EBITDA (X), as of Mar 25, the value is -18.89. This value is below the healthy minimum of 5. It has increased from -34.74 (Mar 24) to -18.89, marking an increase of 15.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For Price / BV (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 24) to 0.98, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For EarningsYield, as of Mar 25, the value is -0.05. This value is below the healthy minimum of 5. It has decreased from -0.03 (Mar 24) to -0.05, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Elango Industries Ltd:
- Net Profit Margin: -22.61%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5.58% (Industry Average ROCE: 13.27%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.74% (Industry Average ROE: 192.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 111.73)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -22.61%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Steel - Alloys/Special | No.5, Ranganathan Garden, 15th Main Road Extension, Chennai (Madras) Tamil Nadu 600040 | admin@kaveripower.com www.elangoindustries.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S Elangovan | Managing Director |
| Mr. S A Premkumar | Director |
| Dr. M Ramasamy | Independent Director |
| Ms. Preethi Natarajan | Independent Director |
| Mrs. Asitha K | Independent Director |
FAQ
What is the intrinsic value of Elango Industries Ltd?
Elango Industries Ltd's intrinsic value (as of 04 November 2025) is 6.86 which is 45.56% lower the current market price of 12.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4.82 Cr. market cap, FY2025-2026 high/low of 16.1/8.45, reserves of ₹-0.05 Cr, and liabilities of 4.71 Cr.
What is the Market Cap of Elango Industries Ltd?
The Market Cap of Elango Industries Ltd is 4.82 Cr..
What is the current Stock Price of Elango Industries Ltd as on 04 November 2025?
The current stock price of Elango Industries Ltd as on 04 November 2025 is 12.6.
What is the High / Low of Elango Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Elango Industries Ltd stocks is 16.1/8.45.
What is the Stock P/E of Elango Industries Ltd?
The Stock P/E of Elango Industries Ltd is .
What is the Book Value of Elango Industries Ltd?
The Book Value of Elango Industries Ltd is 9.88.
What is the Dividend Yield of Elango Industries Ltd?
The Dividend Yield of Elango Industries Ltd is 0.00 %.
What is the ROCE of Elango Industries Ltd?
The ROCE of Elango Industries Ltd is 5.67 %.
What is the ROE of Elango Industries Ltd?
The ROE of Elango Industries Ltd is 5.67 %.
What is the Face Value of Elango Industries Ltd?
The Face Value of Elango Industries Ltd is 10.0.